CSSi LifeSciences™ Partnering Forum 2017 to be held during J.P. Morgan 35th Annual Healthcare Conference
CSSi LifeSciences™, a trusted partner from discovery to commercialization for drugs and medical devices, today announced that it will be hosting its CSSi LifeSciences™ Partnering Forum 2017, during the J.P. Morgan 35th Annual Healthcare Conference. The J.P. Morgan Healthcare Conference will take place from January 9-13, 2017 and is projected to bring in thousands of investors and executives from all over the world to San Francisco, CA. During conference week, companies present their latest innovations and discoveries hoping to acquire a new partner or investor to help further their product to market.
The CSSi LifeSciences™ Partnering Forum 2017 is scheduled to take place from January 9-12, 2017 at the Hilton San Francisco Union Square in Yosemite Ballroom C from 8:00 a.m. - 5:00 p.m. This exclusive event will provide an opportunity to meet strategic investors, learn more about non-dilutive funding opportunities through the NIH SBIR/STTR, and meet key decision makers in the life sciences, pharmaceutical, and medical device communities.
The four-day event will consist of expert-led presentations on market and investment opportunities within drug and technology development, both private and semi-private meetings focused on opportunities and growth challenges, and premier opportunities with industry executives and investors focused exclusively on life sciences.
“We are thrilled to be hosting our partnering event once again during one of the life science industry’s largest conferences of the year,” said Jim Sergi, President of CSSi LifeSciences™. “We designed this event to provide a unique opportunity for participating companies to identify, engage, and enter into strategic relationships and business partnerships that could potentially help drive their businesses successfully forward.”
Additionally, featured guest speakers will present each of the four days of the event on industry-specific topics of interest, sharing the latest news and information that could help power attending companies’ businesses. Partners for the event will include FOCUS Investment Banking, Polsinelli, Borden Ladner Gervais LLP, Innosphere, BioEnterprise, and BioHealth Innovation.
For a full program and to register for CSSi LifeSciences™ Partnering Forum 2017, please visit www.cssilifesciences.com/partneringforum/.
About CSSi LifeSciences™:
CSSi LifeSciences™ provides fully integrated, specialized regulatory and clinical services to support the entire product lifecycle, from discovery to commercialization, for pharmaceutical and medical device companies. With global expertise, CSSi LifeSciences™ has been a key partner in the development of more than 500 drugs, biologics, medical devices, and in-vitro diagnostics. The company’s headquarters is located in Baltimore, MD, with additional offices in San Francisco, CA, London, UK, and Hyderabad, India. For more information, visit www.cssilifesciences.com, email info@cssilifesciences.com, or call (888) 279-8388.
